PARP1 and acute myeloid leukemia: Similarly, treatment of primary blasts derived from AML patients with EAPB02303 revealed PARP-1 and caspase 3 degradation, highlighting the significant EAPB02303-orchestrated apoptotic cell death of AML ex vivo (Figure 2D).